Dr. Matt Binnicker, an expert in the diagnosis of infectious diseases, reviews scenarios where an at-home antigen test is a good option, and when to seek out a lab-based PCR. The omicron variant is ...
The COVID-19 pandemic has seen the rise and fall of many variants, but nothing like BA.5. Previous subvariants of omicron have caused cascading surges as they outcompeted each other; now, BA. 5 is the ...
New COVID-19 restrictions for international travel and other activities are fueling consumer demand for highly accurate polymerase chain reaction, or PCR, tests with rapid turnaround times. Some ...
New guidelines from the U.S. Centers for Disease Control and Prevention (CDC) withdrawing their request for Emergency Use Authorization for a coronavirus test introduced in February 2020 do not mean ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. In the days and weeks before scientists in South Africa and Botswana found Omicron in early November, ...
Add Yahoo as a preferred source to see more of our stories on Google. COVID-19 tests are in greater demand than ever, and new data about the Omicron variant can make picking and using different types ...
Every American traveling abroad needs to take an antigen test to return to the United States. But the start of the trip is often even more cumbersome, as many other countries (nearly every one I have ...
MILFORD, Conn.--(BUSINESS WIRE)--The current Coronavirus chaos is largely caused by phony PCR tests marketed as RT-qPCR assays, explained Dr. Sin Hang Lee, director of Milford, Connecticut-based ...
Researchers at the University of Illinois Chicago have designed a high-quality assay that can be used in at-home tests for rapid COVID-19 screening. Results from an early preclinical study suggest ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
LOS ANGELES--(BUSINESS WIRE)--BiologyWorks™, Inc., a digital healthcare platform company, today announced that a substantive clinical trial of its handheld, reusable molecular test for COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results